NCT01312272 Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia? Status COMPLETED Phase NA
NCT01310998 Acute Psychological Effects of High Intensity Exercise With Schizophrenia Status COMPLETED Phase NA
NCT01309373 An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT01300637 Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients Status UNKNOWN Phase NA
NCT01300364 Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia Status UNKNOWN Phase PHASE4
NCT01299454 A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects Status COMPLETED Phase PHASE1
NCT01299389 An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01298349 Perception Processing in Schizophrenia Patients and Normal Population Status COMPLETED Phase N/A
NCT01295411 Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia Status UNKNOWN Phase NA
NCT01295372 Safety and Efficacy of Zicronapine in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01292577 Adapted Cognitive/Affective Remediation for Cannabis Misuse in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT01289080 Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects Status COMPLETED Phase PHASE1
NCT01284959 Different Safety Profile of Risperidone and Paliperidone Extended-release Status COMPLETED Phase PHASE4